A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers

Conditions:   Uncomplicated Malaria;   Asymptomatic Condition;   Falciparum Malaria Interventions:   Drug: ZY19489 + Ferroquine (FQ);   Drug: Placebo Sponsor:   Zydus Lifesciences Limited Not yet recruiting

Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials